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Sir:
We read the article ‘Anatomic characteristics of bileaflet mitral valve prolapse – 
Barlow disease – in patients undergoing mitral valve repair’ by Rostagno et al. (2014) 
with great interest. In this article, they shared their surgical observations about bileaf-
let mitral valve prolapse (MVP) in terms of mitral valve repair.
We appreciated their experiences on mitral valve repair in patients having MVP. 
However, we have some doubts about the timing of surgery. They reported that 
almost half of the patients were in New York Heart Association functional class 
(NYHA) I or II and that the left ventricular (LV) end-diastolic and end-systolic diam-
eters of the patients were 58.02±6.14 and 34.81±6.88 mm, respectively. Moreover, LV 
ejection fraction of the patients were 62.32±7.11%. All of the above mentioned find-
ings suggest the possibility that surgical intervention was premature in some patients 
according to guidelines (Vahanian et al., 2012). This may result from the good expe-
rience of the surgical team in the repair procedures for MVP. They may desire that 
mitral regurgitation (MR) disappears before impairment in systolic function of LV. 
This may have logical reasons. Instead of replacement, they repair mitral valves, 
thereby i) patients take not so much surgical risk, and ii) they are protected the 
patients from the negative effects of long-term mechanical valve. It is well known 
that capabilities may sometimes influence decision-making process. However, there is 
no randomized clinical trial investigating the optimal timing for surgical intervention 
in patients with MR who are candidate for mitral valve repair. In this context, new 
studies investigating the optimal timing for surgery are needed for patients with MR 
having high probability to undergo mitral valve repair. 
Furthermore, we previously conducted a research on patients with classic MVP 
(Yiginer et al., 2012) and demonstrated that patients with classic bileaflet MVP have 
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enlarged LV even in the absence of moderate or severe MR. LV end-diastolic diame-
ters of 50% patients with MVP were found above the normal limits (>57 mm) in spite 
of the absence of significant MR. Additionally, systolic and diastolic diameters and 
volumes of LV in the MVP group were found to be significantly higher than those in 
the control groups. Ejection fraction of the LV in patients with MVP was not differ-
ent from the healthy controls. MVP, which sometimes accompanies Marfan syndrome 
and Ehler-Danlos syndrome, is a connective tissue disorder of the heart (Delling 
and Vasan, 2014). Mitral valve apparatus is a component of the cardiac fibrous skel-
eton which supports the myocardial muscle as a connective tissue. Coexistences of 
MVP with tricuspid valve prolapse and enlargement of the ascending aorta in some 
patients supports the idea of ‘MVP is a connective tissue disorder of the heart’. In this 
context, Barlow disease is related to pathological and/or geometrical changes of the 
fibrous skeletal  structure of the heart and this may manifest in clinical practice as LV 
enlargement. LV internal diastolic and systolic diameters are essential parameters for 
timing surgical intervention in MVP complicated with MR. Additionally, in grading 
chronic MR, increased LV diameters support the presence of severe MR. Increased LV 
diameters in classic MVP may lead to overestimate of MR and to premature timing 
for surgical intervention. Therefore, being aware of this phenomenon may affect the 
decision about the timing of surgery in the patients with MVP complicated with MR 
in clinical practice.
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